- Home
- MDXH vs NKTR Comparison
MDXH vs NKTR Comparison
Compare MDXH & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- NKTR
- Stock Information
- Founded
- MDXH 2003
- NKTR 1990
- Country
- MDXH Belgium
- NKTR United States
- Employees
- MDXH N/A
- NKTR N/A
- Industry
- MDXH
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- MDXH
- NKTR Health Care
- Exchange
- MDXH Nasdaq
- NKTR Nasdaq
- Market Cap
- MDXH 118.3M
- NKTR 108.3M
- IPO Year
- MDXH 2021
- NKTR 1994
- Fundamental
- Price
- MDXH $2.66
- NKTR $23.06
- Analyst Decision
- MDXH Buy
- NKTR Strong Buy
- Analyst Count
- MDXH 1
- NKTR 6
- Target Price
- MDXH $6.00
- NKTR $81.67
- AVG Volume (30 Days)
- MDXH 98.6K
- NKTR 703.2K
- Earning Date
- MDXH 08-20-2025
- NKTR 08-07-2025
- Dividend Yield
- MDXH N/A
- NKTR N/A
- EPS Growth
- MDXH N/A
- NKTR N/A
- EPS
- MDXH N/A
- NKTR N/A
- Revenue
- MDXH $94,507,000.00
- NKTR $74,934,000.00
- Revenue This Year
- MDXH $23.41
- NKTR N/A
- Revenue Next Year
- MDXH $18.50
- NKTR N/A
- P/E Ratio
- MDXH N/A
- NKTR N/A
- Revenue Growth
- MDXH 25.46
- NKTR N/A
- 52 Week Low
- MDXH $1.35
- NKTR $6.48
- 52 Week High
- MDXH $3.50
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- MDXH 64.90
- NKTR 52.89
- Support Level
- MDXH $2.34
- NKTR $21.60
- Resistance Level
- MDXH $2.93
- NKTR $23.55
- Average True Range (ATR)
- MDXH 0.14
- NKTR 1.46
- MACD
- MDXH 0.02
- NKTR -0.52
- Stochastic Oscillator
- MDXH 54.24
- NKTR 38.27
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.